Search Results
Results found for "Can Cao"
- The Moment Biotech Founders Realize the Money Is Gone
. 👉 How long can we operate if fundraising takes longer than expected? Which decisions can we still reverse, and which ones are already locked in? creates the illusion of control 👉 Many biotech founders  believe they are in control because they can They manage cash flow, but they do not actively track which strategic decisions can still be changed In reality, this is the last window where control can still be regained.
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
assays, signaling assays, cell imaging, protein structure determination, and omics applications, which can Classification: AI models can be used to distinguish GPCRs from non-GPCRs, and to classify GPCRs into Mutations: ML methods can determine stabilising mutations that enable structure determination and can Virtual screening: molecular docking and virtual screening can efficiently analyze large databases of Predicting GPCR properties: AI models can predict various properties of GPCRs, such as ligand binding
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
“…now you have a plethora of 400 models that you can start with molecular dynamics, docking, virtual iteratively refining the models with docking and mutagenesis data, they developed predictive pipelines that can
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
Yet one well-timed question can unlock clarity, accelerate a stalled project, or even spark a collaboration s a masterclass in asking better questions in science, not as a skill you’re born with, but one you can I’m running into a problem and I know you work on something similar — can I pick your brain for one minute
- From Failed Experiments to Predictive GPCR Models
He emphasizes that not every question can be answered computationally—and that saying “we don’t know” In a field where major publications and grant awards can be rare, finding satisfaction in an optimized Modeling a Career on Your Own Terms Carlsson’s career shows that failures can evolve into strengths and that computational insights can transform how we approach GPCRs. early-career researchers, the takeaway is direct: GPCR drug discovery will increasingly depend on those who can
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Learners can study at their own pace, shape the curriculum, and join live monthly AMA sessions with Dr Our access program for researchers in developing countries  continues as well: eligible scientists can 2026, our focus remains simple: keep building with purpose — strengthening what works, refining what can You can always reach me at hello@DrGPCR.org  — and yes, we read every email.
- Understanding Enzyme Inhibition In GPCR Discovery Programs
This week’s feature breaks down exactly how to think about inhibitors with rigor and speed, so you can Why CYP450 allostery can make or break translation from bench to bedside. Now — Premium Members Get Over 50% Discount at Checkout ➤ The Innovation Trap: Why Playing It Safe Can Why micro-domains change what “global” signaling can and can’t explain.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
BBVs are nanoparticles covered with Sf9 cell membranes different from mammalian membranes,[9] which can affect receptors’ properties.[10,11] BBVs also lack downstream signaling components, which can be an The speed of reaching the binding equilibrium is key for this assay, which can be monitored over time Altogether, these aspects hint that the linker design and strategy can provide options for the tuning CELT-419 binding to D3 receptors in cells can be clearly visualized with fluorescence imaging.
- The Hidden Cost of Unclear Biotech Positioning
Positioning 👉 Most biotech founders feel that something is wrong in external conversations long before they can stop adjusting their message mid-conversation , which increases confidence and coherence Alignment can Investors and partners can quickly assess relevance. Founders can quickly assess interest. External stakeholders can decide faster, and founders waste less energy trying to adapt. ✅ If every conversation
- How Early Strategic Decision Making Creates Alignment and Better Results
They give the comforting sense that progress can be measured and managed . Teams believe they can correct course by adjusting execution. How Founders Can Strengthen Strategic Decision Making Early Once founders recognize the role of early decisions and understand how alignment works, the next question becomes practical. 👉 How can strategic Founders who define when and how decisions can be challenged reduce fear and defensiveness later on.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
While these signaling pathways are highly interconnected, they can also be regulated independently (Kenakin In various pathological conditions, including cancer, aberrant ERK activity can lead to uncontrolled ERK activation pathways can be categorised into two main sub-pathways based on their subcellular localisation The choice of pathway can result in different cellular responses, underscoring the criticality of precise understanding the intricacies of GPCR signaling and utilising advanced assay technologies, researchers can
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
In GPCR drug discovery, a single mistaken assumption can derail an entire program. also explores the experimental constraints —like timing and equilibrium—that determine whether you can shape alone is diagnostic, pointing out how features like receptor reserve  or irreversible binding  can
- How Schild Analysis Protects Your Conclusions in GPCR Research
Welcome back GPCR Fans, Clean data can still mislead if the underlying assumptions aren’t tested. But if the underlying criteria aren’t tested, that assumption can quietly erode the reliability of your Quantify affinity you can defend. Â
- Nanobodies: New Dimensions in GPCR Signaling Research
They can recognize cryptic epitopes often composed of discontinuous amino acid segments and occur only Nbs can stabilize specific conformations of proteins, including unstable structural intermediates and Generation, selection and functional expression: Nanobodies can be obtained by immunizing a camelid and Combinatorial biology methods such as phage display, yeast display, and ribosome display can be used Most Nbs can be functionally expressed as genetically encoded intrabodies within a eukaryotic cell.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers class B GPCRs, however, has been more controversial, despite increasing evidence that these receptors can These dimeric forms, which can either be transient or stable, are believed to influence the function Recent studies suggest that class B1 GPCRs can form both homodimers and heterodimers, which may play
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
You'll learn why some agonists succeed in sensitive tissues but fail elsewhere—and how this knowledge can
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Even compounds with pristine target profiles can fail in vivo due to poor absorption, limited tissue Solubility, lipophilicity (e.g., logP), and polarity govern whether molecules can cross membranes, dissolve its path from administration to excretion Minor ADME adjustments —sometimes a single methyl group— can
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Trusting your eyes—or tradition—can cost time, money, and credibility. walks you through which statistical tests actually answer the question you think you’re asking—so you can Get an answer you can defend. Unlock Terry’s Corner ➤ Dr.
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish This combined with the use of polarized light leads to a signal that can only be detected when the fluorescent Conventional membrane preparations or baculoviruses can be used among others.
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
I can image the whole islet. A single successful GPCR imaging experiment can transform a project’s trajectory. Better GPCR imaging doesn’t just capture biology — it expands the biological questions the field can
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
other immune checkpoint inhibitors.1 In a shared effort to develop robust screening approaches  that can They can be used to verify target engagement  and calculate ligand affinity  in a NanoBRET ®-based competitive As a proof of concept, the study shows that Celtarys’ chemistry can be translated into NanoBRET ® TE The next step will be to determine how broadly this approach can be extended across GPCR families and
- GPCR Selectivity Beyond the Receptor
Key implications: SBI-553 illustrates how arrestin signaling can be stabilized through direct receptor–Gαo interface engagement rather than distal conformational effects PCO371 shows that G protein bias can arginine residue, distinct from agonist recognition Explore the masterclass library ➞ Premium Members can
- The Real Cost of Strategic Overload in Biotech
Each move can be justified. Early data can point in multiple promising directions. Letting go of a program can feel like abandoning potential value. Can the entire strategy be explained through one coherent throughline, or does it require layered justifications
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
However, GLP-1R can also engage other G proteins, such as Gi/o and Gq/11, leading to different downstream Biased agonism at the GLP-1R has been extensively studied, revealing that different ligands can stabilize These differences in signaling profiles can have significant physiological implications. observed to reduce adipose tissue size more effectively than exendin, suggesting that biased agonism can
- Do You Believe AI Could Accelerate Drug Discovery?
By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy concern is the reliance on data quality and quantity, where inaccuracies or biases in training data can Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions
- Ever Wondered How Drugs Are Discovered?
and First in Class  projects—and why both are essential Why target-based  discovery is powerful, but can
- Your GPCR Program Decisions Depend on Good Data Interpretation
Subtle misinterpretation can quietly derail projects, slow timelines, and waste scarce resources. GPCR , we’re focusing on the hidden risks that undermine progress and how the right frameworks can keep But Terry Kenakin’s new Emerging Drug Hunter lecture reveals why this assumption can mislead even experienced
- How Collaboration Drives GPCR Discoveries
in vivo work, structural experts for cryo-EM, chemists for tool development, and data scientists who can No one person can be excellent at all of it — and pretending otherwise slows discovery. It will hinge on the teams who can map GPCR signaling with precision and design therapies that fit real
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
simultaneously interact with both Ser2777.42 and His2787.43, 2 only transiently contacts His2787.43, which can This approach can expand the repertoire of adenosine receptor antagonists that can be designed based
- Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges
When antibodies fail to selectively recognize GPCR targets, the resulting data can be difficult to reproduce When antibody specificity is uncertain, variability in experimental outcomes can propagate across studies
























